Resistant hypertension and target organ damage (Q38099742)

28 August 2017

Resistant hypertension and target organ damage (English)

1 reference

28 August 2017

1 reference

Maria Lorenza Muiesan

1

1 reference

28 August 2017

Massimo Salvetti

2

1 reference

28 August 2017

Damiano Rizzoni

3

1 reference

28 August 2017

Anna Paini

4

1 reference

28 August 2017

Claudia Agabiti-Rosei

5

1 reference

28 August 2017

Carlo Aggiusti

6

1 reference

28 August 2017

Enrico Agabiti Rosei

7

1 reference

28 August 2017

18 April 2013

1 reference

28 August 2017

Hypertension Research

1 reference

28 August 2017

36

1 reference

28 August 2017

6

1 reference

28 August 2017

485-491

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2013.30

28 August 2017

0 references

cites work

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Resistant hypertension, secondary hypertension, and hypertensive crises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Resistant hypertension: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Incidence and prognosis of resistant hypertension in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Resistant hypertension and left ventricular hypertrophy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Importance of the electrocardiographic strain pattern in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Regression of left ventricular hypertrophy on long-term treatment with captopril of severe hypertensives refractory to standard triple treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Vascular compliance and arterial calcification: impact on blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Arterial stiffness as a cause of resistant hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prognostic significance of small-artery structure in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

True resistant hypertension: is it possible to be recognized in the office?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Predictors of resistant hypertension in an unselected sample of an adult male population in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Prevalence of resistant hypertension in the United States, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Management of refractory hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Urinary albumin excretion is associated with true resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Cerebral microangiopathy in treatment-resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Vascular hypertrophy and remodeling in secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Factors associated with microalbuminuria in resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Urinary Albumin Excretion Is Associated With Nocturnal Systolic Blood Pressure in Resistant Hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Structural association between the carotid artery and the left ventricle in a general population in Northern Italy: the Vobarno study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.30

7 January 2021

Identifiers

DOI

10.1038/HR.2013.30

1 reference

28 August 2017

1 reference